Decision Of The Minister Of Public Health: Banning Of Any Food Supplement Advertisement In The Mass

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	403,153 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution+diluent	643,765 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g, Lidocaine (ampoule) -	1g	Injectable powder for solution+diluent	568,253 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution+diluent	508,100 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution+diluent	508,100 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution+diluent	643,765 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g, Lidocaine (ampoule) -	1g	Injectable powder for solution+diluent	568,253 L.L
H02AB04	LISAMETHYLE	G	Methylprednisolone sodium succinate - 40mg/2ml	40mg/2ml	Injectable powder for solution+diluent	7,905,545 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution	3,455,595 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution	3,455,595 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	5,793,881 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	5,793,881 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	5,793,881 L.L
A02BC01	LOZICARE	G	Omeprazole - 40mg	40mg	Injectable powder for solution	12,446,972 L.L
A02BC02	LUGANOR	G	Pantoprazole - 40mg	40mg	Injectable lyophilised powder for solution	463,050 L.L
A02BC02	LUGANOR	G	Pantoprazole - 40mg	40mg	Injectable lyophilised powder for solution	4,146,714 L.L
J05AB01	LOVRAK-JULPHAR	G	Aciclovir - 250mg	250mg	Injectable lyophilised powder	278,175 L.L
B05BA02	LIPIDEM	G	Triglycerides, Medium Chain - 100g/500ml, Soya bean oil - 80g/500ml, Omega-3 acid triglicerides - 20g/500ml		Injectable emulsion	2,486,109 L.L
J01GB06	LIKACIN	G	Amikacin (sulfate) - 500mg/2ml	500mg/2ml	Injectable concentrated solution	349,399 L.L
D11AX18	LABDIC RELIEF	G	Diclofenac sodium - 1%w/w, Methyl salicylate - 8%w/w, Menthol - 2%w/w		Gel	263,393 L.L
M02AA15	LOCAGEL	G	Diclofenac sodium (diethylamine) - 10mg/g	10mg/g	Gel	223,078 L.L
D07AB02	LOCOID CRELO 0.1%	B	Hydrocortisone butyrate - 1mg/g	0.1%	Emulsion	177,387 L.L
D07AB02	LOCOID CRELO 0.1%	B	Hydrocortisone butyrate - 1mg/g	0.1%	Emulsion	177,387 L.L
C01AA05	LANOXIN PG	B	Digoxin - 0.05mg/ml	0.05mg/ml	Elixir	307,740 L.L
S01BA14	LOTEMAX	B	Loteprednol etabonate - 0.5%	0.5%	Drops suspension	1,038,790 L.L
S01CA02	LOXTRA	G	Prednisolone acetate - 2mg/ml, Tetrahydrozoline HCl - 0.4mg/ml, Ofloxacin - 3mg/ml		Drops suspension	423,310 L.L
J07CA	LANTIGEN B	B	Streptococcus pneumoniae type 3 (antigenic extracts) - 63.2A.U./ml, Streptococcus pyogenes group A (antigenic extracts) - 126.2A.U./ml, Branhamella catarrhalis (antigenic extracts) - 39.9A.U./ml, Staphylococcus aureus (antigenic extracts) - 79.6A.U./ml, Haemophilus influenzae type b (antigenic extracts) - 50.2A.U./ml, Klebsiella pneumoniae (antigenic extracts) - 39.8A.U./ml		Drops suspension	916,501 L.L
S01XA20	LUBRI-TEARS	G	Carmellose sodium - 2mg		Drops solution	792,867 L.L

قرار لوزير الصحة بمنع الاعلان عن اي متمم غذائي عبر وسائل الاعلام